Penumbra
PEN
$425.42
Share price
-0.76%
Change (1 day)
24.22%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Net assets
Net assets on the balance sheet as of December 2024 : A$1.82 Billion
According to Penumbra's latest financial reports the company has A$1.82 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Penumbra - Net assets on balance sheet (from 2014 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$1.85 B | 6.93% |
| 2023-12-31 | $A$1.73 B | 17.89% |
| 2022-12-31 | $A$1.46 B | 11.55% |
| 2021-12-31 | $A$1.31 B | 58.63% |
| 2020-12-31 | $A$0.82 B | 19.59% |
| 2019-12-31 | $A$0.69 B | 15.67% |
| 2018-12-31 | $A$0.59 B | 16.91% |
| 2017-12-31 | $A$0.51 B | 38.7% |
| 2016-12-31 | $A$0.36 B | 15.85% |
| 2015-12-31 | $A$0.31 B | -2211.71% |
| 2014-12-31 | $-A$15.12 Million | 67.23% |
| 2013-12-31 | $-A$9.04 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | A$0.69 B | -62.23% | 🇺🇸 USA |
 | A$2.19 B | 19.85% | 🇺🇸 USA |